Invictus RG’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-149
Closed -$11K 667
2016
Q2
$11K Sell
149
-339
-69% -$24K 0.01% 481
2016
Q1
$31K Buy
488
+3
+0.6% +$189 0.04% 388
2015
Q4
$33K Buy
+485
New +$32K 0.03% 416

Other funds holding BMY

Invictus RG's BMY Position: Q3 2016 in Review

Invictus RG sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 149 shares — an estimated $11K sold.

Invictus RG first reported a position in BMY in Q4 2015 and held it in 3 quarters. The position peaked at $33K in Q4 2015. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Invictus RG reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Invictus RG sold 149 Bristol-Myers Squibb shares in Q3 2016, an estimated $11K.
  • Invictus RG first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 3 quarters.
  • Invictus RG's Bristol-Myers Squibb position peaked at $33K in Q4 2015.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Invictus RG's 13F filing for Q3 2016, filed 14 Nov 2016.